Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.